12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

Oncodesign, Sanofi deal

The companies partnered to identify and synthesize inhibitors of an undisclosed kinase from Sanofi involved in tissue protection and repair using Oncodesign's Nanocyclix medicinal chemistry technology. Sanofi, which...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >